English | Español

Amgen Inc.
Robert Hadley | Apr 16, 2017

XGEVA pending approval for myeloma patients
Erianne Leatherman | Apr 9, 2017

Amgen’s BLINCYTO to receive priority review from FDA
Erianne Leatherman | Apr 7, 2017

Repatha shows no memory effects while lowering LDL levels, study finds
Robert Hadley | Mar 28, 2017

European Commission approves Amgen's new anti-inflammatory drug
Robert Hadley | Mar 22, 2017

Amgen’s Repatha may help patients with tough cases of high cholesterol
Robert Hadley | Mar 17, 2017

Clinical trial shows immunotherapy can extend leukemia patients' life expectancy
Mark Iandolo | Oct 24, 2016

Amgen announces study regarding its XGEVA product
Amanda Rupp | Oct 3, 2016

Amgen to present new data concerning melanoma, metastatic colorectal cancer treatments

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2025

ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+ Pharmaceuticals
Patient Daily | Jun 16, 2025

American Consumer Institute questions hospital use of 340B Drug Pricing Program
+ Pharmaceuticals
Patient Daily | Jun 13, 2025

Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’